Jola Mehmeti, PharmD Candidate 2018

Jola Mehmeti is a final-year PharmD candidate (’18) at the UConn School of Pharmacy. She earned a B.S. in Pharmacy Studies at UConn (’15) and MBA from Sacred Heart University (’17). She is a CITI-certified researcher with investigative and work experience at a large tertiary care center in Hartford, Connecticut. Connect with her on LinkedIn or send a message to @jolamehmeti.com.
Based on the outcomes of Checkmate-238, the Food and Drug Administration approved nivolumab as adjuvant therapy for the treatment of melanoma.
Jan 12, 2018 @07:30 PM
The National Kidney Foundation’s Dietary Guidelines for adults starting on hemodialysis instructs patients to avoid this tropical treat. Why?
Nov 22, 2017 @02:00 PM
FDA expands approved indications for ibrutinib in August 2017.
Sep 29, 2017 @04:21 AM
5-Fluorouracil is the mainstay of treatment for many cancers, with upwards of 30% rates of adverse effects. DPD deficiency can further amplify these effects and even lead to life-threatening toxicity. Uridine triacetate is FDA approved for 5-FU and capecitabine overdose treatment within 96 hours of administration.
Sep 21, 2017 @02:05 AM
In 2015, American poison centers responded to more than 10,000 tricyclic antidepressant exposures. With this level of prevalence, pharmacists should be prepared to respond to questions regarding TCA toxicity.
Sep 11, 2017 @01:16 AM
How does your pharmacy keep employees happy?
Aug 2, 2016 @08:28 AM
Patients benefit when pharmacists thoroughly assess pain.
Jul 15, 2016 @02:55 AM
Is your organization prepared to handle a cyber attack?
Jun 21, 2016 @03:34 AM
Is diversity a business strategy in your organization?
Jun 14, 2016 @12:23 PM
As the roles of pharmacists expand, so do opportunities for nontraditional practice settings.
Jun 9, 2016 @12:39 PM
Regardless of the outcome, all parties must be prepared to handle the implications of the DEA's decision.
May 31, 2016 @02:12 AM
Once you've decided that you want to participate in research, start early and enter with a goal in mind.
May 23, 2016 @02:49 AM
Transformational leadership may be too much of a good thing.
May 18, 2016 @01:32 AM
The Connecticut General Assembly has voted to expand medical marijuana access to patients younger than 18 years.
May 9, 2016 @08:00 AM
There's a pressing need for patients and health care professionals to quickly recognize and act on the signs of opioid overdose and withdrawal.
Apr 12, 2016 @03:11 AM
Pharmacists must address questions and fears that patients have about the flu vaccine.
Mar 28, 2016 @06:44 AM
Bristol-Myers Squibb recently announced that it's acquiring Padlock Therapeutics, Inc.
Mar 24, 2016 @04:00 AM
One of the most under-recognized and under-addressed barriers to safe and effective care is low vision.
Mar 17, 2016 @09:21 AM
Pharmacokinetic differences in newborns and infants affect drug selection and dosing.
Feb 26, 2016 @02:24 AM
Pharmacists are in pivotal positions to reduce morbidity and lower health costs by assessing and counseling elderly patients at risk for falls.
Feb 2, 2016 @03:28 AM
In a study published in JAMA Internal Medicine, researchers examined whether opioid duration of action is related to risk of unintentional overdose (OD) injury.
Jan 13, 2016 @02:24 AM
Plantsvszombies.info Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.
еще по теме pills24.com.ua

обращайтесь pills24.com.ua